These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease. Asendorf AL; Theis H; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; Ruppert-Junck MC; Pedrosa DJ; Hoenig MC; van Eimeren T Hum Brain Mapp; 2024 Jul; 45(10):e26776. PubMed ID: 38958131 [TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders. Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436 [TBL] [Abstract][Full Text] [Related]
4. Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease. Yoo HS; Kim HK; Lee HS; Yoon SH; Na HK; Kang SW; Lee JH; Ryu YH; Lyoo CH J Neurol; 2024 Aug; 271(8):5213-5222. PubMed ID: 38839638 [TBL] [Abstract][Full Text] [Related]
5. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380 [TBL] [Abstract][Full Text] [Related]
6. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease. Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400 [TBL] [Abstract][Full Text] [Related]
7. Predicting Neuropsychiatric Symptoms of Parkinson's Disease with Measures of Striatal Dopaminergic Deficiency. Bishnoi R; Badir MC; Surya S; Youssef NA Curr Alzheimer Res; 2021; 18(6):499-504. PubMed ID: 34455969 [TBL] [Abstract][Full Text] [Related]
8. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls. Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235 [TBL] [Abstract][Full Text] [Related]
9. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease. Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy. Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374 [TBL] [Abstract][Full Text] [Related]
12. Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease. Shin HW; Chung SJ; Lee S; Cha J; Sohn YH; Yun M; Lee PH Clin Nucl Med; 2020 Aug; 45(8):e342-e348. PubMed ID: 32520498 [TBL] [Abstract][Full Text] [Related]
13. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease. Liu R; Umbach DM; Tröster AI; Huang X; Chen H Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703 [TBL] [Abstract][Full Text] [Related]
14. Physical activity mediates the association between striatal dopamine transporter availability and cognition in Parkinson's disease. Shih CH; Moore K; Browner N; Sklerov M; Dayan E Parkinsonism Relat Disord; 2019 May; 62():68-72. PubMed ID: 30722964 [TBL] [Abstract][Full Text] [Related]
15. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993 [TBL] [Abstract][Full Text] [Related]
16. Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease. Yang R; He C; Zhang P; Li Y; Rong S; Chen X; Qi Q; Gao Z; Chi J; Wang L; Cai M; Zhang Y Parkinsonism Relat Disord; 2024 Sep; 126():107071. PubMed ID: 39053098 [TBL] [Abstract][Full Text] [Related]
17. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824 [TBL] [Abstract][Full Text] [Related]
18. Survival in Parkinson's disease in relation to striatal dopamine transporter binding. Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820 [TBL] [Abstract][Full Text] [Related]
19. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients. Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527 [TBL] [Abstract][Full Text] [Related]
20. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease. Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]